27 results
8-K
EX-10.1
AXLA
Axcella Health Inc.
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
Product, (ii) requests the recall, suspension, or seizure of any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation
8-K
EX-10.1
AXLA
Axcella Health Inc.
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling of any Pharmaceutical Product, (ii) requests the recall
8-K
EX-10.1
1hum 76xxk
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
8-K
EX-10.1
6qdq6fszvzgfopi5 63
7 Sep 21
Entry into a Material Definitive Agreement
4:16pm
10-K
dlzmnfy
23 Mar 20
Annual report
4:12pm
10-Q
8c0fn80 xfjea4ojlul
20 Jun 19
Quarterly report
5:03pm